The Competition Commission of India (CCI) has approved the acquisition of 100% equity shares of Medlife International Private Limited (“Medlife”) by API Holdings Private Limited (“API Holdings”). It also approved the acquisition of up to 19.59% equity share capital of API Holdings by Medlife’s shareholders under Section 31(1) of the Competition Act, 2002.
API is a private company, incorporated in 2019. API directly or through its subsidiaries carries out various business activities including wholesale sale and distribution of drugs; transportation and delivery services primarily focused on pharmaceutical sector; owning technology and intellectual property for developing e- commerce platforms. Medlife is primarily a healthcare company engaged in the wholesale sale and distribution of drugs.
Important takeaways for all competitive exams:
Dr Colleen Begg from South Africa has won the 2026 Prince William Award for Conservation…
Professor Shekhar C. Mande, President of the Indian National Science Academy (INSA), has been appointed…
The winners of the National Gopal Ratna Awards (NGRA) 2026 have been announced. It aims…
Four cheetah cubs have been born to a female cheetah in the wild, increasing the…
India has developed its very own H5N1 subtype Bird Flu Vaccine for Chickens. On November…
On 20 th November 2026, the Prime Minister Narendra Modi formally opened the First Shanghai…